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Multiplexed Exchange-PAINT 
imaging reveals ligand-dependent 
EGFR and Met interactions in the 
plasma membrane
Jeffrey L. Werbin1, Maier S. Avendaño2,3, Verena Becker1, Ralf Jungmann2,3,5, Peng Yin2,3, 
Gaudenz Danuser4,6 & Peter K. Sorger1
Signal transduction by receptor tyrosine kinases (RTKs) involves complex ligand- and time-dependent 
changes in conformation and modification state. High resolution structures are available for individual 
receptors dimers, but less is known about receptor clusters that form in plasma membranes composed 
of many different RTKs with the potential to interact. We report the use of multiplexed super-resolution 
imaging (Exchange-PAINT) followed by mean-shift clustering and random forest analysis to measure 
the precise distributions of five receptor tyrosine kinases (RTKs) from the ErbB, IGF-1R and Met families 
in breast cancer cells. We find that these receptors are intermixed nonhomogenously on the plasma 
membrane. Stimulation by EGF does not appear to induce a change in the density of EGFR in local 
clusters but instead results in formation of EGFR-Met and EGFR-ErbB3 associations; non-canonical 
EGFR-Met interactions are implicated in resistance to anti-cancer drugs but have not been previously 
detected in drug-naïve cells.
ErbB receptors comprise a family of four RTKs (EGFR/ErbB1, Her2/ErbB2, Her3/ErbB3 and Her4/ErbB4) 
with important roles in normal cell physiology and in cancer1. ErbB receptors are primarily thought to signal as 
homo- and heterodimers with other ErbB receptors2, but interactions of ErbB receptors with Met3 and IGF-1R4 
RTKs (“non-canonical” interactions) have been reported, particularly in cells that have acquired resistance to 
ErbB-targeting anti-cancer drugs. Such interactions appear to be weaker than those involving ErbB proteins 
themselves and have not been detected in drug-naïve cells3,5. Immuno-electron microscopy6 and fluorescence 
correlation spectroscopy (FCS)7 have shown that ErbB receptors are non-uniformly distributed in the plasma 
membrane, forming clusters with a characteristic diameter of 100 nm, ~10 times greater than that of an EGFR 
dimer8. Due to limitations in the number of distinguishable immuno-electron probes and FCS-compatible fluoro-
phores, published studies image at most two receptor types at a time7.
Single-molecule localization (SML) imaging techniques such as PALM (photoactivated localization micros-
copy)9,10, STORM (stochastic optical reconstruction microscopy)11,12 and PAINT (Point Accumulation for 
Imaging in Nanoscale Topography) and DNA-PAINT13–15 achieve resolutions of ~10 nm and make it possible 
to visualize protein clusters directly. These methods have been applied primarily to highly organized assemblies 
such as focal adhesions16, centrioles17, nuclear pore complexes18 and the actin cytoskeleton19 for which shape and 
structure are well defined. PALM20,21 and STORM21–23 have also been employed to image single transmembrane 
receptors, however the use of SML imaging techniques to map interactions among families of receptors has not 
yet been reported.
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Here we exploit the multiplexing capabilities of Exchange-PAINT, a multiplexed variant of DNA-PAINT14, 
to image simultaneously five RTKs (EGFR, ErbB2, ErbB3, IGF-1R and Met) at endogenous levels of expression 
in BT20 cancer cells and to examine how receptor distribution changes following ligand stimulation. By using 
machine learning and subsequent biochemical validation we detect ligand-dependent, non-canonical interaction 
of EGFR and Met.
Results
Validation of Exchange-PAINT imaging of RTKs. In Exchange-PAINT dye-labelled “imager” strands 
transiently bind to unlabelled complementary “docking” strands that have been chemically linked to target mol-
ecules. Transient binding of the imager strands achieves the ON/OFF switching of fluorescence signals necessary 
for SML microscopy. The position of each ON/OFF event is referred to as a “localization” and an image is con-
structed by combining ~105–106 localizations for each probe. By using multiple antibodies each having a unique 
docking strand it is possible to sequentially image an equivalent number of molecular targets using a single 
fluorophore and laser source. After completing a round of imaging with one imager strand the sample is washed 5 
times until no more localizations are detectable (~1 min) before adding the next imager strand (Fig. 1a).
Selective anti-receptor antibodies compatible with PAINT were identified by testing commercially available 
reagents on a panel of CHO cell lines each of which transiently over-expressed a single human RTK (CHO express 
few if any endogenous ErbB receptors24) (Fig. 1). Biotinylated monoclonal antibodies were coupled to docking 
strands with a streptavidin linker14 (see online methods and Supplemental Protocol 1), fixed CHO cells were pro-
cessed by standard immunofluorescence protocols, and fluorescence emission was detected using highly inclined 
and laminated optical sheet (HILO) microscopy25; the use of integrated fluidics made it possible to efficiently per-
form sequential washing and imaging steps (Supplemental Fig. S1)14. For each of the five anti-receptor antibodies 
in our final collection we observed specificity for the appropriate over-expressing CHO cell line as measured 
by the total number of localization events (Fig. 1b). To test the reproducibility of the imaging and localization 
assignment, EGFR was imaged before and after imaging the other four receptors: the two EGFR images had a 
normalized cross-correlation coefficient of 0.84 demonstrating minimal physical distortion and good sampling 
of stochastic emissions (Supplemental Fig. S1).
Receptor reorganization in response to EGF stimulation. Images of fixed serum-starved (Fig. 2f) and 
EGF-stimulated (Fig. 2g) BT20 triple negative breast cancer cells, which express all five receptors at detectable 
levels26, were obtained by sequentially imaging the five receptors using the single dye Atto655 (Fig. 2a–e). We 
detected 2–20 × 105 localizations per cell with an average localization precision of 3.9 nm (representing the single 
molecule fitting precision) and resulting in a supported resolution of ~9.3 nm (as defined by the full width at half 
maximum). We also confirmed the localization precision and maximal achievable resolution by comparing the 
positions of super-localized centres from adjacent frames using the distance between neighbouring-frame locali-
zations (DNFL)27. The integral image quality as measured by the Fourier ring correlation method28, a metric that 
combines localization precision, sampling frequency, labeling efficiency and target analyte density into a single 
measure of effective resolution, was 17.7 ± 3.8 nm (Supplemental Note). Importantly in Exchange-PAINT pho-
tobleaching has no significant effect on image acquisition; continuous replenishment of the imaging probe from 
solution results in a constant number of localizations over the course of image acquisition. (Supplemental Fig. S1).
Images of all five receptors showed that their distribution in the plasma membrane was non-uniform as deter-
mined by Ripley’s K-function analysis (Fig. 2 insets; see online methods for details)29. In both serum-starved 
and EGF-stimulated cells, stabilized Ripley’s K-function curves revealed clustering above that expected for 
a random distribution (Fig. 2h,i). Receptors of different types were intermingled in both serum-starved and 
EGF-stimulated cells and there were no obvious patterns corresponding to known receptor homodimers or het-
erodimers post-stimulation. However, parallel experiments demonstrated strong activation of Erk and Akt signal-
ling kinases, events that require receptor oligomerization30, which is consistent with evidence that ErbB receptor 
dimers can be pre-formed in the absence of ligand31. These loose but non-random clumps of RTKs have been 
previously described6 and are thought to have a significant impact on signalling intensity and ligand sensitivity32. 
We hypothesize that EGF exerts its effects on receptors at the level of mesoscopic scale clusters (10–100 nm), but 
at larger scales RTK distributions are not dramatically changed on short time scales prior to receptor uptake, 
recycling and degradation (with occurs within 30–90 mins after exposure of BT20 cells to ligand33).
Analyzing spatial patterns using mean-shift clustering. As a means to better quantify receptor dis-
tribution in the presence and absence of ligand, localizations were grouped into “clusters” of high local density 
using mean-shift clustering (Fig. 3a, online methods)34. Mean-shift clustering preserves information about the 
heterogeneity of receptor distribution while capturing information on local density and composition and requires 
only a single adjustable parameter, the bandwidth (see see online methods for a definition of this term)35. Clusters 
were computed by centering a box, with a width of two times the bandwidth, on each localization and calculating 
the mean position of all localizations within the box. The box was then shifted to this mean and the process was 
repeated until convergence (that is, until the mean was stationary). Localizations that converged to the same point 
were then grouped together and assigned to a cluster. In this analysis we used a fixed bandwidth of 48 nm, which 
was chosen such that localizations arising from two dimerized receptors would fall within one bandwidth of each 
other after accounting for experimental uncertainties (see online methods).
The mean-shift clustering approach was tested using DNA origami nanostructures with known binding site 
number and geometry (Fig. 3b, see Supplemental Fig. S2 for design details). Five origami structures were created, 
each of which carried 48 copies of one of the docking strands used for receptor imaging. The five structures were 
mixed in equal proportions and imaged by Exchange-PAINT (Fig. 3c). Following processing and alignment of the 
images and use of a mean-shift clustering algorithm we observed near-perfect correlation between the original 
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Figure 1. Validation and optimization of Exchange-PAINT for membrane receptor imaging. (a) Five CHO 
cell lines transfected with different human RTKs were fixed, stained and imaged sequentially with 5 rounds of 
Exchange-PAINT (imager strands at 2.5 nM, 15000 frames, 10 Hz imaging rate). The diagonal images show the 
specificity of the imaging method and the specificity of the antibody-DNA conjugates for their cognate targets. 
Scale bars: 5 µm. (b) Specificity quantification of images shown in panel a. Localizations were normalized in 
each group by their maximal number and then the mean was calculated. There are significant differences in the 
number of localizations for each specifically transfected cell line. *P < 0.0001 ANOVA test, confirming high 
specificity.
www.nature.com/scientificreports/
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Figure 2. Multiplexed Exchange-PAINT super-resolution imaging of fixed BT20 cells. (a–e) Five-“colour” 
receptor images. (Top) Schematic of imaging procedure. (Bottom) Exchange-PAINT images. Each receptor 
target is labelled with an antibody carrying a unique Exchange-PAINT docking strand. Imaging is performed 
sequentially using five orthogonal imager strands (a*, b*, c*, d*, e*) all at 2.5 nM and labelled with the 
fluorophore ATTO655. (f,g) Merged images of all five targets for (f) unstimulated or (g) EGF-stimulated 
cells. Inset panels (labelled i to viii) 10-fold higher magnification views of regions of the images in f and g that 
highlight receptor clusters with varied shapes and compositions. Imaging: 15,000 frames per cycle at 10 Hz rate. 
Washing: 1–2 minutes per cycle. (h,i) Ripley’s K-function analysis of multiple regions selected for unstimulated 
(h) and EGF-stimulated cells (i). Mean L(r)—r reports the degree of clustering for several regions in a 
population of cells relative to a random distribution (indicated by the grey line), and r indicates the radius. Scale 
bars in a–g: 5 µm; scale bars for the insets (labelled i-viii) is 1 µm.
www.nature.com/scientificreports/
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Figure 3. Computational clustering of receptors. (a) A schematic of the mean-shift clustering algorithm used 
to group localizations detected by Exchange-PAINT into clusters based on local density. (b) In vitro clustering 
validation. Five types of DNA origami structures (a to e), each displaying 48 DNA-PAINT docking strands, 
were mixed and then imaged sequentially as previously described. (c) Super-resolved Exchange-PAINT image 
of the mixed origami sample on a glass surface. Imaging was performed using Cy3b-labelled imager strands 
at 10 nM, 15,000 frames per cycle, 10 Hz imaging rate. Washing: 1–2 minutes per cycle. Scale bar: 200 nm. (d) 
Localizations from the mixed origami sample in c were grouped into clusters (represented in different colours) 
of high local density as detected by mean-shift clustering. Cluster area is outlined in gray (dashed lines in the 
upper right corner are 3-fold higher magnification views of outline regions in c and d. Scale bars: 200 nm. (e) 
Clusters and their outlines in BT20 cells as detected by mean-shift clustering in the image shown in Fig. 2f. Scale 
bar: 500 nm. (f,g) Quantitative clustering analysis results after Exchange-PAINT imaging of 5 different receptors 
comparing unstimulated and EGF-stimulated BT20 cells.
www.nature.com/scientificreports/
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image and the mean-shift clustering result, demonstrating super-resolution discrimination of localizations arising 
from different probes (Fig. 3d). When mean-shift clustering was applied to Exchange-PAINT data from starved 
(Fig. 3e), and EGF-treated BT20 cells, we found that clusters in EGF-treated cells were smaller (Fig. 3f) and 
denser, having a greater number of localizations per unit area (Fig. 3g). This finding is consistent with the results 
of previous studies that measured ErbB receptor distributions using immunoelectron and scanning near-field 
optical microscopy6,7.
Machine learning suggests locally driven interactions between Met and EGFR. Mean-shift clus-
tering yielded ~5,000–30,000 clusters per BT20 cell (Fig. 3e) each of which was characterized by five features 
corresponding to individual receptor localization densities. We multiplied local receptor densities with each other 
to create 15 additional features that represented the likelihood that two receptors were in close proximity within a 
cluster. To identify which of the resulting 20 features maximally distinguish starved and stimulated cells we used 
Random Forests (RFs)36, a supervised machine learning approach that captures non-linear relationships among 
heterogeneous types of data. We trained 100 random forests from sub-samples of the data and computed the 
importance of each of the 20 features in classifying if a cluster was in a starved or EGF- treated cell (Fig. 4a and 
Figure 4. Random forest and biochemical analysis detect cross-stimulation of Met by EGFR following ligand 
exposure. (a) Random forest classification of non-linear combinations of features that reflect molecular 
interactions between receptors. Feature importance was calculated by repeatedly generating random forests 
from sub-samples of the data. (b) Biochemical analysis of Met-EGFR interaction. Serum-starved BT20 cells 
were pre-treated for 15 min with 1 µM Gefitinib for EGFR or SU11274 for Met or DMSO as a control and 
then stimulated for 5 min with EGF (which binds EGFR) and/or HGF (which binds Met) or medium as a 
control. Receptor immunoprecipitates were subjected to SDS-PAGE and immunoblots were probed with an 
anti-phospho-tyrosine antibody, anti-EGFR or anti-Met antibodies and respective secondary antibodies. The 
full length blots are presented in Supplementary Fig. 8. (c) Background-subtracted phospho-Met signals were 
corrected for total Met expression, normalized to the EGF/HGF-treated sample and plotted as mean with 
standard deviation derived from three biological replicates.
www.nature.com/scientificreports/
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Supplemental Notes). The forests on average could correctly classify 69.4% (StDev. 0.19%) of the clusters on aver-
age. We found that d(EGFR)*d(Met) (where d refers to density within a cluster) was the most significant feature 
and d(EGFR)*d(ErbB3) was the second most important feature, suggesting that EGFR becomes co-confined with 
Met and ErbB3 in membrane microdomains following EGF stimulation. EGFR and ErbB3 are known to form 
functional heterodimers in response to EGF stimulation37,38 and Met and EGFR have been reported to interact in 
cells that have become resistant to anti-ErbB drugs3,39–41. Receptor dimers known to mediate the effects of EGF 
such as EGFR-EGFR and EGFR-ErbB2 were well down the feature importance list, suggesting that the relatively 
abundant EGFR and ErbB2 receptors are not undergoing significant reorganization at the mesoscopic scale in 
the time frame of ligand stimulation (5 min). This observation is also consistent with the potential existence of 
preformed dimers in serum-starved cells31.
Synergistic cross-stimulation of Met by EGFR. As an independent means to determine if EGFR and 
Met functionally interact in BT20 cells, we immunoprecipitated receptors from starved and ligand-treated 
cells and examined levels of phosphorylation by immunoblotting of precipitates using a pan-specific 
anti-phosphotyrosine antibody (Fig. 4b). Compared to unstimulated cells, we observed that Met phosphoryla-
tion increased ~4-fold upon exposure of cells to EGF (as compared to ~45-fold upon exposure to the Met-ligand 
HGF) (Fig. 4c). Concurrent treatment of cells with EGF and HGF was synergistic in promoting Met phospho-
rylation (Fig. 4c) across a range of ligand concentrations (Supplemental Fig. S3). Conversely, treatment of cells 
with small-molecule inhibitors targeting EGFR (Gefitinib) or Met (SU11274) prior to EGF addition decreased 
Met phosphorylation levels, suggesting that both kinases contribute to cross-activation of Met (Fig. 4b,c). Similar 
results were obtained for inhibitor experiments in cells co-stimulated with EGF and HGF (Supplemental Fig. S4). 
Thus, Met and EGFR appear to interact at the level of trans-phosphorylation in BT20 cells. However, we were 
unable to co-immunoprecipitate the two receptors at levels above background (data not shown), suggesting that 
interactions are low-affinity or indirect42.
Discussion
In this paper we demonstrate the use of multi-target Exchange-PAINT and machine learning to quantify the 
spatial distribution of five receptors on the plasma membrane of human cells. These receptors were not primarily 
found in clusters containing a single receptor type but rather were comingled in non-random patches character-
ized by heterogeneity on multiple length scales. At the outset we had assumed that SML would reveal patterns 
of receptor co-localization consistent with patterns of receptor homo- and hetero-oligomerization identified by 
biochemical studies1,2. However, the most significant differences between starved and EGF-treated cells involve 
EGFR-ErbB3 and non-canonical EGFR-Met interactions previously detected in receptor over-expressing cells5,43 
and implicated in resistance to ErbB-targeting therapies3. This implies that ongoing attempts to jointly inhibit 
ErbB and Met in cancer cells44 have a rationale in receptor biophysics. We speculate that relatively low feature 
importance assigned to d(EGFR) and d(EGFR*EGFR) in the classification of ligand-treated vs. untreated cells 
is that due to the high abundance of these receptors only minimal changes in their mesoscale densities occur on 
the time scale of the stimulation, minutes. Our results are also consistent with the presence of preformed dimers 
or clusters of EGFR.
Exchange-PAINT has several useful properties for studying transmembrane receptors: (1) simplicity of imple-
mentation on conventional microscopes, (2) extendibility to additional receptors and multiple cell lines, and (3) 
ability to identify subtle differences in receptor localization between cell types or cells before and after ligand 
addition. The availability of antibodies is the primary experimental limitation to the number of receptors that 
can be imaged simultaneously, but it would theoretically be possible to image all 58 human RTKs with ~10 nm 
resolution in a native cellular environment.
It is clear that there is much yet to be learned about the organization of RTKs in the plasma membrane and we 
believe that Exchange-PAINT and machine learning will be potent tools for studying the distribution and inter-
action of membrane proteins, including those that are being targeted therapeutically using antibody-based drugs. 
Such drugs are also ideal detection reagents for Exchange-PAINT. With respect to data analysis, we experimented 
with a number of approaches before choosing mean-shift clustering and random forest algorithms because they 
were biologically interpretable and well-suited to characterizing complex distributions (Supplemental Notes). 
However, we anticipate that other statistical techniques will also prove useful in the interpretation of multiplex 
Exchange-PAINT data. We therefore provide all images and localization data in this paper as supplementary 
material and at http://lincs.hms.harvard.edu/werbin-sci-rep-2017/.
Methods
Materials. Non-modified and amino-modified DNA oligonucleotides were purchased from Integrated DNA 
Technologies (Coralville, IA). Fluorescently labelled DNA oligonucleotides were purchased from Biosynthesis 
(Lewisville, TX).
Plasmids. To clone ErbB receptor-mEOS2 fusion constructs, mEOS2 DNA (a gift from Michael Davidson) 
with a 5′-GGSGG-3′ linker was inserted into the first variable region of the pQCXIP plasmid (CloneTech) 
between AgeI and EcoRI. ErbB receptors EGFR, ErbB2, or ErbB3 (a gift from William Hahn & David Root, 
Addgene plasmids #23935, #23888, and #23874, respectively)45 were amplified by PCR amplification and inserted 
into NotI and AgeI sites of pQCXmEOS2IP (To be deposited at Addgene).
Cell culture. BT20 cells were obtained from ATCC and cultivated in EMEM (ATCC, Manassas, VA) 
supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA) and 1% 
Penicillin-Streptomycin (PS). CHO cells were cultivated in F-12K (ATCC, Manassas, VA) supplemented with 10% 
www.nature.com/scientificreports/
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FBS and 1% PS and transfected with pQC-EGFR-mEOS2-IP, pQC-ErbB2-mEOS2-IP, pQC-ErbB3-mEOS2-IP, 
pBabe-IGF-1R (a gift from Ronald Kahn, Addgene plasmid #11212)46 or pBabe-Met (a gift from Joan Brugge, 
Addgene plasmid #17493)47 using TurboFect (Thermo Scientific, Waltham, MA).
Super-resolution optical setup. Fluorescence imaging was carried out on an inverted Nikon Eclipse Ti 
microscope (Nikon Instruments, Melville, NY) with the Perfect Focus System, applying an objective-type TIRF 
configuration using a Nikon TIRF illuminator with an oil-immersion objective (CFI Apo TIRF 100× , NA 1.49, 
Oil), corresponding to a final pixel size of 160 nm. Two lasers were used for excitation: 561 nm (200 mW nominal, 
Coherent Sapphire) (for diffraction limited imaging) and 647 nm (300 mW nominal, MBP Communications, 
Canada) (for Exchange-PAINT). The laser beam was passed through cleanup filters (ZET561/10, and ZET640/20, 
Chroma Technology, Bellows Falls, VT) and coupled into the microscope objective using a multi-band beam 
splitter (ZT561rdc/ZT640rdc, Chroma Technology). Fluorescence light was spectrally filtered with emission fil-
ters (ET600/50 m, and ET700/75 m, Chroma Technology) and imaged on an EMCCD camera (iXon X 3 DU-897, 
Andor Technologies, North Ireland).
Antibody-DNA conjugates. Antibody-DNA conjugates used to specifically label receptors with 
DNA-PAINT docking sites were preassembled in three steps. Three buffers were used for sample preparation and 
imaging: Buffer A (10 mM Tris-HCl, 100 mM NaCl, 0.05% Tween-20, pH 7.5), buffer B (5 mM Tris-HCl, 10 mM 
MgCl2, 1 mM EDTA, 0.05% Tween-20, pH 8), and buffer C (1× PBS, 500 mM NaCl, pH 8).
Labelling streptavidin. Streptavidin (Cat. No. 43-4302, Invitrogen, Carlsbad, CA) was mixed with biotinylated 
oligo (bt-oligo) (Integrated DNA Technologies, Coralville, IA) at a 1:3 molar ratio and incubated for 30 min at 
room temperature. This maximizes the amount of the streptavidin in the 3 × (bt-oligo) state; ideal amount is 
~40% as estimated by the binomial distribution.
Separating triply oligo bound streptavidin. A GE MonoQ 5/50 was cleaned with 1 ml of 2 M NaCl and then equil-
ibrated with 15 ml of buffer 1 (20 mM Tris pH 6.3, 300 mM NaCl). The streptavidin-oligo reaction was brought 
to 20 mM Tris pH 6.3 and then diluted to 400 µl with buffer 1 before being applied to the column. 5 ml of buffer 1 
was run on the column at a flow rate of 0.2 ml/min, and then a linear gradient between 20% buffer 2 (20 mM Tris 
pH 6.3, 1 M NaCl) and 40–65% (depending on the oligo) over the course of 25 min. Unlabelled streptavidin does 
not bind to the column and the single, double, triple and quadruple labelled streptavidin came off the column in 
well separated peaks (Supplemental Fig. S5). The triply labelled fractions were collected and brought to ~100 mM 
Tris-HCl pH 7.4. Labelling biotinylated antibodies. Biotinylated monoclonal antibodies against EGFR (Cat. No. 
6627, Cell Signaling, Danvers, MA), ErbB2 (custom biotinylation of clone 242D, BioLegend, San Diego, CA), 
ErbB3 (Cat. No. 324704, BioLegend, San Diego, CA), IGF-1R (Cat. No. MA5-13799, Thermo Scientific, Waltham, 
MA) or Met (Cat. No. 8041, Cell Signaling, Danvers, MA) were mixed with the triply labelled streptavidin at a 
1:2 molar ratio, incubated at room temperature for 30 min and then concentrated using a 10 kDa cutoff Amicon 
4 ml spin concentrator (UFC801024, Millipore, Billerica, MA) until the antibody concentration was >1 mg/ml. 
Concentrated antibody conjugates were diluted to a final concentration of 0.5 mg/ml for EGFR, ErbB2, ErbB3 
and IGF-1R or 0.085 mg/ml for Met in ~35 mM Tris pH 7.4, 300 mM NaCl, 1 mg/ml BSA, 0.2% NaAzide, 50% 
Glycerol and stored at −20 °C.
Sample preparation, acquisition, and analysis for Exchange-PAINT imaging of BT20 and CHO 
cells. Coated Lab-Tek II chambers. 8-well Lab-Tek II chambered coverglass (Cat. No. 155409, Thermo 
Scientific, Waltham, MA) were coated with fibronectin (Cat. No. F1141, Sigma Aldrich, St. Louis, MO) at a con-
centration of 10 µg/ml FN in PBS (containing Ca and Mg) for 1 hour at 37 °C, then washed with PBS.
Sample preparation. BT20 cells were seeded in coated 8-well Lab-Tek II chambered coverglass, washed twice 
and starved overnight in serum-free medium (EMEM). One hour prior to stimulation, cells were re-starved to 
remove autocrine ligands and then exposed to EGF (Peprotech, Princeton, NJ) at saturating concentration (10 µg/
mL) for 5 min or to medium alone as a control. Stimulated and starved cells were immunostained using the fol-
lowing procedure: fixation with 4% paraformaldehyde for 30 min; washing twice with TBS; reduction with 1 mg/
ml NaBH4 for 7 min; washing three times with TBS; permeabilization and blocking with blocking buffer (0.3% 
(v/v) Triton X-100 and 3% BSA in TBS) for at least 2 hours; blocking endogenous avidin and biotin (Cat. No. 
00-4303, Invitrogen, Carlsbad, CA) and staining overnight with preassembled antibody-DNA conjugates against 
EGFR, ErbB2, ErbB3, IGF-1R (diluted to 3 µg/ml in blocking buffer), and Met (diluted to 0.56 µg/ml in blocking 
buffer) at 4 °C. CHO cells were seeded in coated Lab-Tek II chambered coverglass 24 hours after transfection, 
starved overnight and fixed and stained as described above.
Imaging conditions. A Lab-Tek II chamber was adapted for fluid exchange as shown in Supplemental Fig. S1. 
For Figs 1 and 2 and Supplemental Fig. S1, 2.5 nM Atto 655-labelled imager strands in buffer C were used. Each 
image acquisition step was followed with a brief ~1 min washing step consisting of at least five washes using 200 µl 
of buffer C each. Then the next imager strand solution was introduced. The chamber was monitored throughout 
the washing procedure to ensure complete exchange of imager solutions. Acquisition and washing steps were 
repeated until all five receptor targets were imaged. The CCD readout bandwidth was set to 3 MHz at 14 bit and 
5.1 pre-amp gain. No EM gain was used. Imaging was performed using highly inclined (HILO) illumination25 as 
described above with an excitation power of ~50 mW and imaging intensity of ~0.2 kW/cm2 using the 647 nm 
laser line.
www.nature.com/scientificreports/
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Data analysis. Super-resolution images were reconstructed using spot-finding and 2D-Gaussian fitting algo-
rithms in LabVIEW13,14. Analysis programs are available for download at http://www.dna-paint.net or http://
molecular-systems.net.
DNA origami self-assembly. DNA origami structures displaying 48 Exchange-PAINT docking strands 
were self-assembled in a one-pot reaction with 50 µl total volume containing 10 nM scaffold strand M13mp18 
(New England Biolabs, Ipswich, MA), 100 nM folding staples, 100 nM biotinylated staples, and 1 µM DNA-PAINT 
docking staple strands in folding buffer (1 × TE Buffer with 12.5 mM MgCl2). The solution was annealed using a 
thermal ramp cooling from 90 °C to 20 °C over the course of 1.5 h. After self-assembly, structures were purified 
by agarose gel electrophoresis (2% agarose, 0.5 × TBE, 10 mM MgCl2, 0.5 × SybrSafe) at 4.5 V/cm for 1.5 h. Gel 
bands were cut, crushed and filled into a Freeze ‘N Squeeze column (Bio-Rad, Hercules, CA) and spun for 5 min 
at 800 × g at 4 °C. After this, structures were ready for preparation as microscope samples followed by image 
acquisition.
DNA sequences. Staple sequences for DNA origami structures with 48 docking strands and fixed Cy3 dyes 
can be found in Supplemental Table S1. M13mp18 scaffold sequence for DNA origami structures can be found 
in Supplemental Table S2. Exchange-PAINT docking and imager strands sequences and biotin docking strands 
sequence can be found in Supplemental Table S3.
Sample preparation, imaging, and analysis of DNA origami structures. Sample preparation. For 
fluid exchange, a custom flow chamber was constructed similar as in cellular imaging. For binding of the origami 
structures to the surface of the flow chamber first, 20 µl of biotin-labelled bovine albumin (Sigma Aldrich, St. 
Louis, MO; 1 mg/ml, in buffer A) was applied to the chamber and incubated for 2 min. The chamber was then 
washed using 40 µl of buffer A. 20 µl of streptavidin (0.5 mg/ml, in buffer A) was then flown through the chamber 
and allowed to bind for 2 min. After washing with 40 µl of buffer A and subsequently with 40 µl of buffer B, 20 µl 
of biotin-labelled DNA structures (~300 pM) in buffer B were finally flown into the chamber and incubated for 
5 min. The chamber was washed using 40 µl of buffer B.
Imaging conditions. Sequential imaging was done as described for BT20 cell imaging, but the washing steps 
were performed using buffer B. The imaging buffer contained 10 nM Atto 655-labelled imager strands in buffer 
B (Fig. 3c). Acquisition and washing steps were repeated until all five origami structures were imaged. The CCD 
readout bandwidth was set to 3 MHz at 14 bit and 5.1 pre-amp gain. No EM gain was used. Imaging was per-
formed using TIRF25 illumination with an excitation power of ~50 mW and an imaging intensity of ~0.2 kW/cm2 
using the 647 nm laser line.
Data analysis. Super-resolution images were reconstructed as described before.
Drift correction. In vitro imaging. Drift correction was performed using a custom-written MATLAB pro-
gram. The positions of all DNA origami structures was tracked throughout the duration of each movie and aver-
aged for use as the drift correction trace.
In situ imaging. For cellular imaging, 100 nm gold nanoparticles (Sigma Aldrich, St. Louis, MO; 10 nM in buffer 
C, added before imaging) were used as drift markers. The gold nanoparticles adsorb non-specifically to the glass 
bottom of the imaging chambers. Drift correction is performed in a similar fashion as for the in vitro imaging (see 
above). The apparent “movement” of all gold nanoparticles in a field of view is tracked throughout the movie. The 
trajectories thus obtained are averaged and used for global drift correction of the final super-resolution image.
Image alignment. All single colour images are aligned by fitting a 2D Gaussian to the common drift markers 
and finding the x-y translation that best aligns the markers to the IGF-1R image. This translation is applied to all 
localizations before further analysis.
Ripley’s K analysis. A modified version of Ripley’s K function was used to analyze the localization images 
for each channel separately. The modified version of the Ripley’s statistic here referred to as L(r)-r is a transforma-
tion of the K(r) function so that random point distributions produce zero response at all spatial scales. To prevent 
edge artefacts L(r) was calculated for several small rectangular regions of interest (ROIs) from within each cell 
such that the edge of the cell was not included in the ROI.
∑∑= <An I d rK(r) ( ) (1)i j ij
pi
=L r K r( ) ( )
(2)
Here, n is the number of points contained within the ROI but are at least a distance of r from the edge, dij is the 
distance between two points i and j, r is the analyzed spatial scale, and I is an indication function with a value of 1 
if the statement is true and 0 if false. This function is a measure of the number of points, j, enclosed in concentric 
circles of radius r centred on each point i. The K-function scales with circle area for a completely spatially random 
case, and L scales linearly with area. For ease of interpretation we plot L(r)-r vs r which has an expected value of 0 
for all r in the case of randomly distributed points (see Fig. 2).
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Mean-shift clustering analysis. Localizations from 5 images were merged into a single list and mean shift 
clustering was applied with a 48 nm bandwidth. The bandwidth is defined as half of the width of the square win-
dow used in Mean-Shift clustering. Thus when the window is centred on a localization the bandwidth determines 
the furthest distance to another localization that will be considered to potentially belong to the same cluster. Here 
the bandwidth was chosen from first principles such that if two receptors are dimerized any localizations from 
bound antibodies will fit within the analysis window simultaneously. By way of illustration consider the case in 
which localizations arising from binding of two oligo-coupled antibodies to a single receptor dimer are as far 
apart as possible in the imaging plane. In this case a) antibodies bind to the receptors as far as possible from the 
dimerization interface placing the two antibodies ~8 nm from each other48, b) the antibodies lie in the plane of 
the membrane and point away from each other (10 nm per antibody)49. We must also consider c) the distance 
between biotin binding sites of ~3 nm50, d) the length of 10 bp ssDNA of ~3 nm51 and e) the localization uncer-
tainty from fitting the dyes of approximately 4 nm per dye. When all of these uncertainties are added together we 
obtained 20 nm for each antibody + 8 nm for the receptors so that localizations from a single receptor dimer could 
be appear to be as far apart as 48 nm. We therefore used this distance as the bandwidth parameter for mean-shift 
clustering. The convex hull of each cluster was calculated and used to define the area of the cluster. We defined 
the composition as the number of localizations of each receptor type within the cluster and the densities as the 
number of localization divided by the cluster area in nm2. If a cluster had fewer than 12 localizations in total it 
was discarded because it is likely to be noise. This cut-off is derived from considering that a single bound anti-
body should yield ~43 localizations (see below for justification). Only clusters that were internal to a cell and at 
least 100 nm from either the cell or image boundary were kept for further analysis. The cluster densities of n = 11 
unstimulated (serum-starved) cells were compiled into an n cluster by 5-feature array, where the features are the 
localization densities for each receptor type. The same procedure was applied to n = 11 EGF stimulated cells.
Rationale for excluding cluster with fewer than 12 localizations. Each antibody is labelled on average with 6 DNA 
oligo binding strands as determined by FPLC in Supplemental Fig. S5. At a concentration of 2.5 nM imager 
strands an average of 7.2 localizations13 is expected per target strand while imaging a single “channel”. The small-
est real cluster must contain at least one antibody and at least one streptavidin molecule with 6 target strands. 
Assuming that localizations are distributed according to a Poisson process with a rate of λ = (7.2 localizations/
(imaging period*strand)) * 6 strands = 43.2 localizations/imaging period, the probability of an antibody having 
producing exactly 12 localizations is given by λ λ−e /12!12  ~1.5 × 10−8 and the probability of 12 or fewer localiza-
tion is given by λ∗ ∑λ− =e n/ !n
n
0
12  ~ 2 × 10−8. Given that ~2 × 105 clusters were observed before applying this 
cut-off, it is unlikely that any localizations arising from a real antibody were discarded.
Random forest analysis. The family of RTKs tested in this work requires formation of dimers for signal-
ling. Thus, in addition to examining receptor densities, we constructed features for each cluster describing the 
coupling of receptor densities. This was accomplished by pairwise multiplication of the individual receptor local-
ization densities (features), creating 15 additional features for each cluster (since multiplication is commutative 
there are only 15 unique features of the form featurei* featurej). Our training matrix was therefore of the form 
(nunstimulatedClusters + munstimulatedClusters) × 20 features. Each cluster was labelled with either 0 or 1 to indicate that the 
cluster was from an unstimulated or stimulated cell respectively. This data was used to generate a random forest 
using the Matlab function treeBagger which is part of the Matlab Statistics and Machine Learning toolbox. All 
forests in this paper were grown with 50 trees (NTrees = 50), with a minimum number of observations per leaf of 
300 (MinLeaf = 300) and with variable importance prediction turned on.
We then calculated 100 random forests from random sub-samples of our data. This allowed us to remove 
class imbalance and estimate uncertainty of the variable importance measure. The sub-samples were generated 
by randomly selecting 66% of the unstimulated data and then randomly selecting an equal amount of stimulated 
data. From this data a random forest was trained and the variable importance (mean delta error) for each feature 
was recorded.
The variable importance of the ith feature was calculated by taking the out of bag (OOB) data for each tree 
in the forest and determining the percentage of correct classification, ErrorOOB. Then, the ith feature of the 
OOB data was scrambled and the classification error Error_ithRandom calculated. The delta error was defined 
as ErrorOOB – Error_ithRandom. The reported mean delta error is the mean of this number over all trees in the 
forest. This number was recorded for all 20 features for each sub-sampling of the data. The results are presented 
in Fig. 4a.
Sample preparation and analysis of immunoprecipitates. To prepare detergent lysates, BT20 cells 
were seeded in 60 mm-dishes or 100 mm-dishes, washed twice and starved for 15–18 hours in serum-free 
medium (EMEM). One hour prior to the start of the experiment, cells were re-starved to remove autocrine lig-
ands. If not otherwise indicated, cells were pre-treated for 15 min at 37 °C with 1 µM Gefitinib or SU11274 (Selleck 
Chemicals, Houston, TX) or with DMSO as a control and subsequently stimulated for 5 min at 37 °C with EGF 
(10 µg/ml), HGF (300 ng/ml), both ligands together or culture medium as a control (ligands from Peprotech, 
Princeton, NJ). Cells were transferred to ice, washed with ice-cold PBS and lysed with a 1% NP40 lysis buffer 
(1% NP40, 150 mM NaCl, 20 mM Tris pH 7.5, 10 mM NaF, 1 mM EDTA pH 8.0, 1 mM ZnCl2 pH 4.0, 1 mM 
MgCl2, 1 mM Na3VO4, 10% Glycerol) supplemented with Complete mini/EDTA-free protease inhibitors (Roche, 
Penzberg, Germany). Cleared lysates were subjected to immunoprecipitation by incubating samples with rab-
bit antibodies against EGFR (Cat. No. 6627, Cell Signaling, Danvers, MA) or Met (Cat. No. sc-10, Santa Cruz, 
Dallas, TX) and Protein A-coupled Dynabeads (Invitrogen, Carlsbad, CA). Immunoprecipitates were washed 
twice with 1% NP40 lysis buffer and once with TNE buffer (10 mM Tris pH 7.5, 100 mM NaCl, 1 mM EDTA pH 
8.0, 100 µM Na3VO4), resuspended in 1 × NuPage LDS Sample Buffer supplemented with 50 mM DTT, boiled for 
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3 min at 95 °C, and loaded on Novex 3–8% Tris-Acetate gels (Invitrogen, Carlsbad, CA). Immunoblots were per-
formed using the iBlot Gel Transfer Stacks PVDF system (Invitrogen, Carlsbad, CA). After blocking with Odyssey 
Blocking Buffer (Licor, Lincoln, NE), membranes were incubated with primary (mouse anti-phosphotyrosine 
antibodies, Cat. No. 05-321, Millipore, Billerica, MA; rabbit anti-EGFR antibodies, Cat. No. 4267, Cell Signaling, 
Danvers, MA; rabbit anti-Met antibodies, Cat. No. 8041, Cell Signaling, Danvers, MA) and secondary antibodies 
(anti-mouse antibodies coupled to DyLight 680, Cat. No. 35518 or anti-rabbit antibodies coupled to DyLight 800, 
Cat. No. 35571, from Thermo Scientific, Waltham, MA) diluted in Odyssey Blocking Buffer. Membranes were 
scanned on a Licor Odyssey CLx scanner using the 700 and 800 nm channels set to automatic intensity with a 
169 µm resolution. Protein levels were quantified with the Licor Image Studio 4.0.21 software using the build-in 
manual analysis tool with a median local background correction. Intensity values for phospho-Met were divided 
by intensity values for total Met expression from the same blot and were subsequently normalized to the EGF/
HGF-stimulated sample. Relative protein levels between conditions (phosphorylated and total receptor) were 
derived from the same blot.
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